Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study.

Muñoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shah KV, Meijer CJ, Bosch FX; International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group..

Lancet. 2002 Mar 30;359(9312):1093-101.

PMID:
11943256
2.

Smoking and cervical cancer: pooled analysis of the IARC multi-centric case--control study.

Plummer M, Herrero R, Franceschi S, Meijer CJ, Snijders P, Bosch FX, de Sanjosé S, Muñoz N; IARC Multi-centre Cervical Cancer Study Group..

Cancer Causes Control. 2003 Nov;14(9):805-14.

PMID:
14682438
3.

Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.

Castellsagué X, Díaz M, de Sanjosé S, Muñoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS, Snijders PJ, Meijer CJ, Bosch FX; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group..

J Natl Cancer Inst. 2006 Mar 1;98(5):303-15.

4.

Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study.

Moreno V, Bosch FX, Muñoz N, Meijer CJ, Shah KV, Walboomers JM, Herrero R, Franceschi S; International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group..

Lancet. 2002 Mar 30;359(9312):1085-92.

PMID:
11943255
5.

Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study.

Franceschi S, Rajkumar T, Vaccarella S, Gajalakshmi V, Sharmila A, Snijders PJ, Muñoz N, Meijer CJ, Herrero R.

Int J Cancer. 2003 Oct 20;107(1):127-33.

6.

HPV types and cofactors causing cervical cancer in Peru.

Santos C, Muñoz N, Klug S, Almonte M, Guerrero I, Alvarez M, Velarde C, Galdos O, Castillo M, Walboomers J, Meijer C, Caceres E.

Br J Cancer. 2001 Sep 28;85(7):966-71.

7.

Causes of cervical cancer in the Philippines: a case-control study.

Ngelangel C, Muñoz N, Bosch FX, Limson GM, Festin MR, Deacon J, Jacobs MV, Santamaria M, Meijer CJ, Walboomers JM.

J Natl Cancer Inst. 1998 Jan 7;90(1):43-9.

8.

Risk factors for cervical cancer in Thailand: a case-control study.

Chichareon S, Herrero R, Muñoz N, Bosch FX, Jacobs MV, Deacon J, Santamaria M, Chongsuvivatwong V, Meijer CJ, Walboomers JM.

J Natl Cancer Inst. 1998 Jan 7;90(1):50-7.

9.

Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.

Wallin KL, Wiklund F, Angström T, Bergman F, Stendahl U, Wadell G, Hallmans G, Dillner J.

N Engl J Med. 1999 Nov 25;341(22):1633-8.

10.

High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women.

Sasagawa T, Basha W, Yamazaki H, Inoue M.

Cancer Epidemiol Biomarkers Prev. 2001 Jan;10(1):45-52.

11.

The viral origin of cervical cancer in Rabat, Morocco.

Chaouki N, Bosch FX, Muñoz N, Meijer CJ, El Gueddari B, El Ghazi A, Deacon J, Castellsagué X, Walboomers JM.

Int J Cancer. 1998 Feb 9;75(4):546-54.

12.

Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States.

Altekruse SF, Lacey JV Jr, Brinton LA, Gravitt PE, Silverberg SG, Barnes WA Jr, Greenberg MD, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Hildesheim A.

Am J Obstet Gynecol. 2003 Mar;188(3):657-63.

PMID:
12634637
13.
14.

Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer.

Smith JS, Herrero R, Bosetti C, Muñoz N, Bosch FX, Eluf-Neto J, Castellsagué X, Meijer CJ, Van den Brule AJ, Franceschi S, Ashley R; International Agency for Research on Cancer (IARC) Multicentric Cervical Cancer Study Group..

J Natl Cancer Inst. 2002 Nov 6;94(21):1604-13.

15.

Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction (PCR).

Yamakawa Y, Forslund O, Teshima H, Hasumi K, Kitagawa T, Hansson BG.

Gynecol Oncol. 1994 May;53(2):190-5.

PMID:
8188078
16.

Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies.

Castellsagué X, Díaz M, Vaccarella S, de Sanjosé S, Muñoz N, Herrero R, Franceschi S, Meijer CJ, Bosch FX.

Lancet Oncol. 2011 Oct;12(11):1023-31. doi: 10.1016/S1470-2045(11)70223-6.

PMID:
21917519
17.

Risk factors for cervical neoplasia in Denmark.

Kjaer SK.

APMIS Suppl. 1998;80:1-41.

PMID:
9693662
18.

The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University.

Pilch H, Günzel S, Schäffer U, Tanner B, Brockerhoff P, Maeurer M, Höckel M, Hommel G, Knapstein PG.

Int J Gynecol Cancer. 2001 Jan-Feb;11(1):39-48.

PMID:
11285032
19.

Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix.

Lacey JV Jr, Swanson CA, Brinton LA, Altekruse SF, Barnes WA, Gravitt PE, Greenberg MD, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Kurman RJ, Hildesheim A.

Cancer. 2003 Aug 15;98(4):814-21.

20.

HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica.

Hildesheim A, Herrero R, Castle PE, Wacholder S, Bratti MC, Sherman ME, Lorincz AT, Burk RD, Morales J, Rodriguez AC, Helgesen K, Alfaro M, Hutchinson M, Balmaceda I, Greenberg M, Schiffman M.

Br J Cancer. 2001 May 4;84(9):1219-26.

Items per page

Supplemental Content

Support Center